Press-release for stocks related to fda

Prices are updated after-hours

tags : Fda

save search

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Published: 2024-04-09 (Crawled : 10:00) - prnewswire.com
BCLI A | $0.5384 4.69% 4.48% 1M

Health Technology

| -23.88% | O: 10.45% H: 0.0% C: 0.0%
fda als cell for trial therapeutics agreement

ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -4.65% | O: -0.39% H: 0.0% C: 0.0%
fda approval for hiv living

Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M

Health Technology

| -16.98% | O: 26.42% H: 3.48% C: -6.47%
ocu400 fda first clearance trial therapy

FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
Published: 2024-04-06 (Crawled : 16:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
fda treatment for car-t

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
carvykti fda first approved one treatment for therapy

U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
Published: 2024-04-05 (Crawled : 14:00) - biospace.com/
TSVT | $4.52 -2.59% -2.65% 610K

| 1.0% | O: 7.98% H: 9.06% C: -9.06%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -6.03% | O: -0.41% H: 0.51% C: 0.25%
fda for therapy

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.48% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -3.37% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.35% | O: -3.44% H: 0.0% C: 0.0%
fda for

IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
Published: 2024-04-05 (Crawled : 13:00) - globenewswire.com
IRME | $0.969 108.33% 980

| -11.54% | O: 0.0% H: 4.62% C: 4.62%
fda device for

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
Published: 2024-04-05 (Crawled : 12:00) - globenewswire.com
TARA | $2.62 -4.73% -4.96% 210K

Health Technology

| -31.59% | O: 16.92% H: 11.06% C: -22.77%
fda nutrition for therapeutics

iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency in the U.S.
Published: 2024-04-04 (Crawled : 23:00) - biospace.com/
DTIL | $9.75 -9.05% -9.95% 170K

Health Technology

| -30.57% | O: -2.33% H: 1.64% C: -4.91%
ecur-506 fda drug treatment clearance for application trial

Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M

Health Technology

| -11.67% | O: 1.32% H: 1.41% C: -2.17%
cb-010 fda lupus clearance

Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.12% | O: -1.51% H: 0.0% C: 0.0%
fda approval

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
HAE | $81.24 -2.66% -1.65% 850K

Health Technology

| 0.22% | O: 0.05% H: 1.54% C: 0.19%
teg fda clearance global

Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
Published: 2024-04-03 (Crawled : 23:00) - prnewswire.com
BW | News | $0.9279 -4.18% 0.0% 1.1M

Electronic Technology

| -18.25% | O: 1.69% H: 2.5% C: -4.17%
fda clearance system

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology